DRUG-MONOCLONAL ANTIBODY CONJUGATES FOR CANCER-THERAPY - POTENTIALS AND LIMITATIONS

被引:0
|
作者
PIMM, MV
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:189 / 227
页数:39
相关论文
共 50 条
  • [1] DRUG-MONOCLONAL ANTIBODY CONJUGATES FOR CANCER-THERAPY
    REISFELD, RA
    VARKI, NM
    WALKER, LE
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 410 - 410
  • [2] ANTIBODY DRUG CONJUGATES FOR CANCER-THERAPY
    UPESLACIS, J
    AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION, 1992, 56 (04) : 464 - 467
  • [3] ANTIBODY-DRUG CONJUGATES FOR CANCER-THERAPY
    REISFELD, RA
    YANG, HM
    MULLER, B
    WRASIDLO, W
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1989, 197 : 86 - MEDI
  • [4] DRUG-ANTIBODY CONJUGATES FOR CANCER-THERAPY
    BALDWIN, RW
    BRITISH JOURNAL OF CANCER, 1986, 54 (03) : 536 - 536
  • [5] CANCER-THERAPY USING DRUG-ANTIBODY CONJUGATES
    BURSTEIN, S
    ACTA PHARMACEUTICA SUECICA, 1976, 13 : 19 - 19
  • [6] ANTIBODY-DRUG CONJUGATES FOR CANCER-THERAPY - PROMISES AND PROBLEMS
    REISFELD, RA
    MUELLER, BM
    SCHRAPPE, M
    WARGALLA, U
    YANG, HM
    WRASIDLO, W
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 1991, 11 (02) : 341 - 358
  • [7] THE ROLE OF MONOCLONAL ANTIBODY-A7 AS A DRUG MODIFIER IN CANCER-THERAPY
    KITAMURA, K
    MIYAGAKI, T
    YAMAOKA, N
    TSURUMI, H
    NOGUCHI, A
    YAMAGUCHI, T
    TAKAHASHI, T
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1993, 36 (03) : 177 - 184
  • [8] USE OF VASOACTIVE AGENTS TO INCREASE TUMOR PERFUSION AND THE ANTITUMOR EFFICACY OF DRUG-MONOCLONAL ANTIBODY CONJUGATES
    SMYTH, MJ
    PIETERSZ, GA
    MCKENZIE, IFC
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1987, 79 (06) : 1367 - 1373
  • [9] Advances and Limitations of Antibody Drug Conjugates for Cancer
    Mckertish, Candice Maria
    Kayser, Veysel
    BIOMEDICINES, 2021, 9 (08)
  • [10] Monoclonal antibody drug conjugates in the treatment of cancer
    Trail, PA
    Bianchi, AB
    CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (05) : 584 - 588